🇺🇸 FDA
Patent

US 8557818

Compounds useful as protein kinase inhibitors

granted A61PA61P1/16A61P19/08

Quick answer

US patent 8557818 (Compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P1/16, A61P19/08, A61P25/00, A61P25/28